Man Group PLC Halozyme Therapeutics, Inc. Transaction History

Man Group PLC

$49.7 Billion
Q2 2025

A detailed history of Man Group PLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 140,306 shares of HALO stock, worth $9.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

140,306

Previous 4,194 3245.4%

Holding current value

$9.33 Million

Previous $267,000 2633.33%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$47.91 - $70.14 $6.52 Million - $9.55 Million	136,112 Added 3245.4%	140,306 $7.3 Million
Q1 2025 May 15, 2025	SELL	$47.74 - $65.16 $488,571 - $666,847	-10,234 Reduced 70.93%	4,194 $267,000
Q4 2024 Feb 14, 2025	SELL	$42.57 - $61.09 $3.4 Million - $4.88 Million	-79,910 Reduced 84.71%	14,428 $689,000
Q3 2024 Nov 14, 2024	SELL	$51.3 - $64.42 $5.3 Million - $6.65 Million	-103,245 Reduced 52.25%	94,338 $5.4 Million
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $7.66 Million - $10.6 Million	-202,485 Reduced 50.61%	197,583 $10.3 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $1.76 Million - $2.19 Million	52,261 Added 15.03%	400,068 $16.3 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $10.4 Million - $13.1 Million	312,323 Added 880.18%	347,807 $12.9 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $3.11 Million - $3.76 Million	-85,399 Reduced 70.65%	35,484 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $3.41 Million - $4.37 Million	112,777 Added 1391.28%	120,883 $4.36 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $266,363 - $451,504	8,106 New	8,106 $309,000
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $3.81 Million - $4.96 Million	-96,415 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $5.8 Million - $9.79 Million	-224,531 Reduced 69.96%	96,415 $4.12 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $5.18 Million - $5.96 Million	201,253 Added 168.14%	320,946 $8.43 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $585,162 - $965,428	36,010 Added 43.03%	119,693 $3.21 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $5.3 Million - $8.33 Million	-381,371 Reduced 82.01%	83,683 $1.51 Million
Q4 2019 Feb 18, 2020	SELL	$14.93 - $19.53 $3.92 Million - $5.13 Million	-262,679 Reduced 36.1%	465,054 $8.25 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $2.05 Million - $2.38 Million	134,675 Added 22.71%	727,733 $11.3 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $2.68 Million - $3.13 Million	-181,520 Reduced 23.43%	593,058 $10.2 Million
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $7.29 Million - $9.19 Million	-522,868 Reduced 40.3%	774,578 $12.5 Million
Q4 2018 Feb 14, 2019	BUY	$13.33 - $18.66 $1.59 Million - $2.23 Million	119,394 Added 10.13%	1,297,446 $19 Million
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $8.23 Million - $9.08 Million	493,449 Added 72.08%	1,178,052 $21.4 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $6.31 Million - $7.59 Million	373,805 Added 120.27%	684,603 $11.5 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $5.3 Million - $6.59 Million	310,798 New	310,798 $6.09 Million

Others Institutions Holding HALO

# of Institutions

623

Shares Held

127M

Call Options Held

408K

Put Options Held

388K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.26B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account